## CHD: Church & Dwight Company, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.7% below STRENGTH zone (4.0-10.0%); PEG 1.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($81.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Citi drops sell rating on Church & Dwight as 2026 outlook improves, valuation reflects headwinds (CHD:NYSE)**
- Source: Seeking Alpha | 20251217T130738 | Bullish | Relevance: 100%
- Citi Research has upgraded Church & Dwight (CHD) from a Sell rating, citing recent strategic actions and a 20% year-to-date retracement that better aligns the stock's valuation with its fundamentals. The improved outlook for 2026 is supported by easier comparisons, the sale of its vitamin gummy business, the acquisition of Touchland, and potential consumer trade-down to value brands, with sales acceleration and gross profit margin recovery expected.

**2. Bath Savings Trust Co Decreases Stock Holdings in Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251219T085524 | Somewhat-Bullish | Relevance: 100%
- Bath Savings Trust Co reduced its stake in Church & Dwight Co., Inc. by 7.7% in the third quarter, selling 13,021 shares and now owning 156,348 shares valued at $13.7 million. Despite this, Church & Dwight reported strong Q3 earnings, beating analyst expectations, and announced a quarterly dividend. The company maintains a consensus "Hold" rating from analysts with an average target price of $99.47.

**3. Jefferies upgrades Church & Dwight stock to Buy on valuation reset**
- Source: Investing.com Australia | 20251218T000821 | Bullish | Relevance: 100%
- Jefferies upgraded Church & Dwight Co. Inc. (NYSE:CHD) from Hold to Buy, raising its price target to $102.00 from $97.00. The upgrade reflects a valuation reset for Church & Dwight shares, which are now trading at approximately 22 times forward earnings, near ten-year lows. This positioning offers an attractive entry point ahead of an anticipated improved outlook for 2026, driven by easier comparisons, favorable consumer views in key categories, and market share gains.

**4. Thurston Springer Miller Herd & Titak Inc. Has $185,000 Position in Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251217T142707 | Somewhat-Bullish | Relevance: 100%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 91.8% during the third quarter, holding 2,112 shares valued at $185,000. Despite this, other hedge funds increased their positions, while institutional investors collectively own 86.60% of the company's stock. Analysts currently hold a "Hold" consensus rating for CHD with an average price target of $99.47, following mixed Q3 earnings where the company beat estimates and provided positive guidance.

**5. Citigroup Upgrades Church & Dwight to Neutral From Sell, Adjusts Price Target to $87 From $85**
- Source: marketscreener.com | 20251217T104757 | Somewhat-Bullish | Relevance: 100%
- Citigroup has upgraded Church & Dwight (CHD) from a "Sell" rating to "Neutral" and increased its price target from $85 to $87. This upgrade reflects a more positive outlook on the household products company's stock performance. Concurrently, Jefferies also upgraded Church & Dwight to "Buy" from "Hold", further indicating a growing analyst endorsement.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $87 | $85 | +2% |
| 2025-12-17 | Jefferies | $102 | $97 | +5% |
| 2025-12-10 | Deutsche Bank | $100 | $102 | -2% |
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | up | Neutral |
| 2025-12-17 | Jefferies | up | Buy |
| 2025-12-10 | Deutsche Bank | main | Buy |
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 18 ($0.04M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 9.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.95 elevated, pricing in significant growth expectations. Forward P/E 22.7x stretched relative to 7% growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.7B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.95 |
| Forward P/E | 22.7 |
| Current P/E | 24.4 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.8% to 0.7% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >4.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 52. OFD pattern: +SLH (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.73% (CS: 58) | Neutral |
| RSI_14 | 52.1 | Neutral |
| MACD Histogram | 0.31 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 0.903x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $85.05
- **Stop Loss:** $81.69 (4.0% risk)
- **Target:** $88.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $30,362.85
- **Portfolio %:** 30.36%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*